Delcor Asset Corporation et al v. Glenmark Pharmaceuticals Limited et al
||Delcor Asset Corporation and Mylan Pharmaceuticals Inc.
||Glenmark Pharmaceuticals Limited, Glenmark Pharmaceuticals Inc., USA and Stiefel West Coast, LLC
||November 15, 2017
||US District Court for the District of Delaware
||Richard G. Andrews
|Nature of Suit:
||Patent - Abbreviated New Drug Application
|Cause of Action:
|Jury Demanded By:
Access additional case information on PACER
Available Case Documents
The following documents for this case are available for you to view or download:
|October 31, 2018
MEMORANDUM ORDER providing claim construction for multiple terms in U.S. Patent Nos. 7,141,237 and 7,374,747. Signed by Judge Richard G. Andrews on 10/31/2018. (nms)
|September 21, 2018
MEMORANDUM ORDER: The Partial Motion to Dismiss Glenmark's Third Counterclaim (D.I. 28 ) is GRANTED. Signed by Judge Richard G. Andrews on 9/21/2018. (nms)
Use the links below to access additional information about this case on the US Court's PACER system.
A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?